KMDS
E-submission
Search
- Page Path
- HOME > Search
Viewpoint
- Future of Tanscranial Magnetic Stimulation in Movement Disorders: Introduction of Novel Methods
- Yoshikazu Ugawa, Yasushi Shimo, Yasuo Terao
- J Mov Disord. 2020;13(2):115-117. Published online April 6, 2020
- DOI: https://doi.org/10.14802/jmd.19083
- 4,513 View
- 201 Download
- 4 Citations
-
PDF
Supplementary Material -
Citations
Citations to this article as recorded by
- Cortical mean diffusivity is reliable in measuring brain abnormalities in drug-naïve essential tremor patients
Eek-Sung Lee, Peter Lee, Min Seung Kim, Suk Ki Chang, Sang Won Jo, Seun Ah Lee, Suk Yun Kang
Clinical Neurology and Neurosurgery.2023; 230: 107796. CrossRef - Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim, Rudolph E. Tanzi
Frontiers in Neuroscience.2022;[Epub] CrossRef - Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases
Fahad A. Somaa, Tom A. de Graaf, Alexander T. Sack
Frontiers in Neurology.2022;[Epub] CrossRef - Tapping the Potential of Multimodal Non-invasive Brain Stimulation to Elucidate the Pathophysiology of Movement Disorders
Sakshi Shukla, Nivethida Thirugnanasambandam
Frontiers in Human Neuroscience.2021;[Epub] CrossRef
- Cortical mean diffusivity is reliable in measuring brain abnormalities in drug-naïve essential tremor patients
Brief communication
- Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
- Juan Miguel Pilar Bautista, Genko Oyama, Maierdanjiang Nuermaimaiti, Satoko Sekimoto, Fuyuko Sasaki, Taku Hatano, Kenya Nishioka, Masanobu Ito, Atsushi Umemura, Yuji Ishibashi, Yasushi Shimo, Nobutaka Hattori
- J Mov Disord. 2020;13(1):57-61. Published online January 31, 2020
- DOI: https://doi.org/10.14802/jmd.19051
- 5,328 View
- 150 Download
- 5 Citations
-
Abstract
PDF - Objective
The long-term efficacy of deep brain stimulation (DBS) for motor fluctuations in advanced Parkinson’s disease (PD) has been well established; however, motor fluctuations may recur over time despite multiple adjustments of DBS settings and medications.
Methods
We conducted a retrospective chart review of three patients for whom levodopa-carbidopa intestinal gel (LCIG) was additionally administered as a rescue therapy for secondary DBS failure due to the recurrence of motor fluctuations.
Results
The three patients had advanced PD with a disease duration of 14–19 years, and had undergone DBS for motor fluctuations refractory to standard medical management. LCIG was administered to the patients because of symptom recurrence years after DBS and provided complementary effects in all patients.
Conclusion
The cases presented here show that rescue LCIG therapy may be a complementary treatment option for patients with post-DBS advanced PD who have a recurrence of troublesome motor complications. -
Citations
Citations to this article as recorded by- Combining Device‐Aided Therapies in Parkinson's Disease: A Case Series and a Literature Review
Iro Boura, Nikolaos Haliasos, Ιrene‐Areti Giannopoulou, Dimitrios Karabetsos, Cleanthe Spanaki
Movement Disorders Clinical Practice.2021; 8(5): 750. CrossRef - Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
Daniël van Poppelen, Annelie N.M. Tromp, Rob M.A. de Bie, Joke M. Dijk
Journal of Personalized Medicine.2021; 11(6): 547. CrossRef - Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
Valentina Leta, Haidar S. Dafsari, Anna Sauerbier, Vinod Metta, Nataliya Titova, Lars Timmermann, Keyoumars Ashkan, Michael Samuel, Eero Pekkonen, Per Odin, Angelo Antonini, Pablo Martinez-Martin, Miriam Parry, Daniel J. van Wamelen, K. Ray Chaudhuri
Journal of Personalized Medicine.2021; 11(8): 773. CrossRef - Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
Yassine Noui, Monty Adam Silverdale, Julian Evans, Lucy Partington-Smith, Christopher Kobylecki
Journal of Movement Disorders.2021; 14(3): 239. CrossRef - The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?
Joke M. Dijk, Alberto J. Espay, Regina Katzenschlager, Rob M.A. de Bie, Bastiaan R. Bloem, Patrik Brundin
Journal of Parkinson's Disease.2020; 10(s1): S65. CrossRef
- Combining Device‐Aided Therapies in Parkinson's Disease: A Case Series and a Literature Review
First
Prev
